The prevalence of tardive dyskinesia in fluphenazine-treated patients.
One hundred thirty-five outpatients were evaluated for tardive dyskinesia (TD). Of the fluphenazine-treated patients (N = 63), 32 were found to have TD as compared with 29 of 72 non-fluphenazine-treated patients. This difference was not statistically significant. There was no difference in duration and total dose of fluphenazine injections between TD and non-TD patients. However, patients receiving fluphenazine injections were found to require fewer hospitalizations after fluphenazine therapy was started.
Yassa
R
R
Douglas Hospital Centre, Verdun, Québec, Canada.
Iskandar
H
H
Ally
J
J
D000375:Aging / Q000502:physiology; D000978:Antiparkinson Agents / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000978:Antiparkinson Agents; D005476:Fluphenazine